By agreement with the publisher, this book is accessible by the search feature, but cannot be browsed.
Copyright © 1999, American Society for
Neurochemistry.
Bookshelf ID: NBK28045
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Siegel GJ, Agranoff BW, Albers RW, et al., editors. Basic Neurochemistry: Molecular, Cellular and Medical Aspects. 6th edition. Philadelphia: Lippincott-Raven; 1999.
Basic Neurochemistry: Molecular, Cellular and Medical Aspects. 6th edition.
Show details- 1.
- Molinoff P B , Axelrod J . Biochemistry of catecholamines. Annu. Rev. Biochem. 1971;40:465–500. [PubMed: 4399447]
- 2.
- Goldstein, D. S., Eisenhofer, G., and McCarty, R. (eds.) Catecholamines: Bridging Basic Science with Clinical Medicine. New York: Academic Press, 1998.
- 3.
- Shiman R , Akino M , Kaufman S . Solubilization and partial purification of tyrosine hydroxylase from bovine adrenal medulla. J. Biol. Chem. 1971;246:1330–1340. [PubMed: 5545077]
- 4.
- Grima B , Lamouroux A , Blanot F , Biguet N F , Mallet J . Complete coding sequence of rat tyrosine hydroxylase mRNA. Proc. Natl. Acad. Sci. USA. 1985;82:617–621. [PMC free article: PMC397092] [PubMed: 2857492]
- 5.
- Christenson J G , Dairman W , Udenfriend S . Preparation and properties of homogeneous aromatic l-amino acid decarboxylase from hog kidney. Arch. Biochem. Biophys. 1970;141:356–367. [PubMed: 4991409]
- 6.
- Craine J E , Daniels G , Kaufman S . Dopamine β-hydroxylase: The subunit structure and anion activation of the bovine adrenal enzyme. J. Biol. Chem. 1973;248:7838–7844. [PubMed: 4750430]
- 7.
- Lamouroux A , Vigny A , Biguet N F . et al. The primary structure of human dopamine β-hydroxylase: Insights into the relationship between the soluble and the membrane-bound forms of the enzyme. EMBO J. 1987;6:3931–3937. [PMC free article: PMC553871] [PubMed: 3443096]
- 8.
- Connett R J , Kirshner N . Purification and properties of bovine phenylethanolamine-N-methyltransferase. J. Biol. Chem. 1970;245:329–334. [PubMed: 5412063]
- 9.
- Baetge E E , Suh Y H , Joh T H . Complete nucleotide and deduced amino acid sequence of bovine phenylethanolamine N-methyltransferase: Partial amino acid homology with rat tyrosine hydroxylase. Proc. Natl. Acad. Sci. USA. 1986;83:5454–5458. [PMC free article: PMC386305] [PubMed: 2874553]
- 10.
- Liu Y , Peter D , Roghani A . et al. A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter. Cell. 1992;70:539–551. [PubMed: 1505023]
- 11.
- Weinshilboum R M , Thoa N B , Johnson D G , Kopin I J , Axelrod J . Proportional release of norepinephrine and dopamine β-hydroxylase from sympathetic nerves. Science. 1971;174:1349–1351. [PubMed: 5135722]
- 12.
- Alousi A , Weiner N . The regulation of norepinephrine synthesis in sympathetic nerves: Effect of nerve stimulation, cocaine and catecholamine-releasing agents. Proc. Natl. Acad. Sci. USA. 1966;56:1491–1496. [PMC free article: PMC220010] [PubMed: 4382063]
- 13.
- Goldstein, M. Long- and short-term regulation of tyrosine hydroxylase. In F. E. Bloom and D. J. Kupfer (eds.), Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press, 1995, pp. 189–196.
- 14.
- Zigmond R E , Schwarzschild M A , Rittenhouse A R . Acute regulation of tyrosine hydroxylase by nerve activity and by neurotransmitters via phosphorylation. Annu. Rev. Neurosci. 1989;12:415–461. [PubMed: 2564757]
- 15.
- Costa, E., and Sandler, M. Monoamine Oxidase: New Vistas. New York: Raven, 1972.
- 16.
- Nikodejevic B , Sinoh S , Daly J W , Creveling C R . Catechol-O-methyltransferase II: A new class of inhibitors of catechol-O-methyltransferase; 3,5-dihydroxy-4-methoxybenzoic acid and related compounds. J. Pharmacol. Exp. Ther. 1970;174:83–93. [PubMed: 5432229]
- 17.
- Axelrod J . Noradrenaline: Fate and control of its biosynthesis. Science. 1971;173:598–606. [PubMed: 4397955]
- 18.
- Amara S G , Kuhar M J . Neurotransmitter transporters: Recent progress. Annu. Rev. Neurosci. 1993;16:73–93. [PubMed: 8096377]
- 19.
- Bjorklund, A., and Hokfelt, T. (eds.) Handbook of Chemical Neuroanatomy. New York: Elsevier, 1984.
- 20.
- Langer S Z . Presynaptic regulation of catecholamine release. Biochem. Pharmacol. 1974;23:1793–1800. [PubMed: 4617579]
- 21.
- Gingrich J A , Caron M G . Recent advances in the molecular biology of dopamine receptors. Annu. Rev. Neurosci. 1993;16:299–321. [PubMed: 8460895]
- 22.
- Sibley D R , Monsma F J Jr. Molecular biology of dopamine receptors. Trends Pharmacol. Sci. 1992;13:61–68. [PubMed: 1561715]
- 23.
- Minneman K P , Dibner M D , Wolfe B B , Molinoff P B . β1- and β2-adrenergic receptors in rat cerebral cortex are independently regulated. Science. 1979;204:866–868. [PubMed: 35829]
- 24.
- Kobilka B . Adrenergic receptors as models for G protein-coupled receptors. Annu. Rev. Neurosci. 1992;15:87–114. [PubMed: 1575451]
- 25.
- U'Prichard D C , Snyder S H . Distinct α-noradrenergic receptors differentiated by binding and physiological relationships. Life Sci. 1979;24:79–88. [PubMed: 33313]
- 26.
- Bylund D B . Subtypes of α1- and α2-adrenergic receptors. FASEB J. 1992;6:832–839. [PubMed: 1346768]
- 27.
- Hieble J P , Bylund D B , Clarke D E . et al. International Union of Pharmacology recommendation for nomenclature of α1-adrenoceptors: Consensus update 1995. Pharmacol. Rev. 1995;47:267–270. [PubMed: 7568329]
- 28.
- Creese, I., Burt, D. R., and Snyder, S. H. Biochemical actions of neuroleptic drugs: Focus on the dopamine receptor. In L. L. Iversen, S. D. Iversen, and S. H. Snyder (eds.), Handbook of Psychopharmacology. New York: Plenum, 1978, Vol. 10, pp. 37–90.
- 29.
- Lefkowitz R J . G protein-coupled receptor kinases. Cell. 1993;74:409–412. [PubMed: 8394218]
- 30.
- Ferguson S , Barak S G , Zhang L S , Caron M G . G protein-coupled receptor regulation: Role of G protein-coupled receptor kinases and arrestins. Can. J. Physiol. Pharmacol. 1996;74:1095–1110. [PubMed: 9022829]
- 31.
- Sterne-Marr R , Benovic J L . Regulation of G protein-coupled receptors by receptor kinases and arrestins. Vitam. Horm. 1995;51:193–234. [PubMed: 7483322]
- 32.
- Zhou Q -Y , Quaife C J , Palmiter R D . Targeted disruption of the tyrosine hydroxylase gene reveals that catecholamines are required for mouse fetal development. Nature. 1995;374:640–643. [PubMed: 7715703]
- 33.
- Thomas S A , Palmiter R D . Disruption of the dopamine beta-hydroxylase gene in mice suggests roles for norepinephrine in motor function, learning, and memory. Behav. Neurosci. 1997;111:579–589. [PubMed: 9189272]
- 34.
- Giros B , Jaber M , Jones S R , Wightman R M , Caron M G . Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature. 1996;379:606–612. [PubMed: 8628395]
- 35.
- Takahashi N , Miner L L , Sora I . et al. VMAT2 knockout mice: Heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity. Proc. Natl. Acad. Sci. USA. 1997;94:9938–9943. [PMC free article: PMC23302] [PubMed: 9275230]
- 36.
- Link R E , Stevens M S , Kulatunga M , Scheinin M , Barsh G S , Kobilka B K . Targeted inactivation of the gene encoding the mouse α(2C)-adrenoceptor homol. Mol. Pharmacol. 1995;48:48–55. [PubMed: 7623774]
- 37.
- Rohrer D K , Desai K H , Jasper J R . et al. Targeted disruption of the mouse β-1-adrenergic receptor gene: Developmental and cardiovascular effects. Proc. Natl. Acad. Sci. USA. 1996;93:7375–7380. [PMC free article: PMC38992] [PubMed: 8693001]
- 38.
- Mantzoros C S , Qu D , Frederich R C . et al. Activation of β(3) adrenergic receptors suppresses leptin expression and mediates a leptin-independent inhibition of food intake in mice. Diabetes. 1996;45:909–914. [PubMed: 8666142]
- 39.
- Grujic D , Susulic V S , Harper M E . et al. β3-Adrenergic receptors on white and brown adipocytes mediate β3-selective agonist-induced effects on energy expenditure, insulin secretion, and food intake. A study using transgenic and gene knockout mice. J. Biol. Chem. 1997;272:17686–17693. [PubMed: 9211919]
- 40.
- Xu M , Hu X T , Cooper D C . et al. Elimination of cocaine-induced hyperactivity and dopamine-mediated neurophysiological effects in dopamine D1 receptor mutant mice. Cell. 1994;79:945–955. [PubMed: 8001143]
- 41.
- Drago J , Gerfen C R , Westphal H , Steiner H . D1 dopamine receptor-deficient mouse: Cocaine-induced regulation of immediate-early gene and substance P expression in the striatum. Neuroscience. 1996;74:813–823. [PubMed: 8884777]
- 42.
- Baik J H , Picetti R , Saiardi A . et al. Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors. Nature. 1995;377:424–428. [PubMed: 7566118]
- 43.
- Accili D , Fishburn C S , Drago J . et al. A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice. Proc. Natl. Acad. Sci. USA. 1996;93:1945–1949. [PMC free article: PMC39888] [PubMed: 8700864]
- 44.
- Waymire J C , Craviso G L . Multiple site phosphorylation and activation of tyrosine hydroxylase. Adv. Prot. Phosphatases. 1993;7:501–513.
- References - Basic NeurochemistryReferences - Basic Neurochemistry
- Rhoh ras homolog family member H [Rattus norvegicus]Rhoh ras homolog family member H [Rattus norvegicus]Gene ID:305341Gene
Your browsing activity is empty.
Activity recording is turned off.
See more...